Calado, Jerlita R.
HRN: 00-95-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/29/2024
08/05/2024
IVT
600mg
Q6
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes